BridgeBio Pharma, Inc.
BBIO
$66.54
$2.013.12%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/4/2026
-
Globe Newswire
3/4/2026
-
MarketBeat
3/3/2026
-
MarketBeat
3/3/2026
-
Insider Monkey
3/3/2026
-
Yahoo! Finance: News
3/3/2026
-
Insider Monkey
3/2/2026
-
Simply Wall St
3/2/2026
-
MarketBeat
3/1/2026
-
MarketBeat
3/1/2026
-
MarketBeat
2/28/2026
-
Simply Wall St
2/27/2026
-
Simply Wall St
2/25/2026
-
Simply Wall St
2/25/2026
-
MarketBeat
2/25/2026
-
MarketBeat
2/25/2026
-
MarketBeat
2/25/2026
-
MarketBeat
2/25/2026
-
TipRanks Financial Blog
2/25/2026
-
Zacks Investment Research
2/25/2026
-
Seeking Alpha: Transcripts
2/25/2026
-
SeekingAlpha
2/24/2026
-
MarketBeat
2/24/2026
-
Ticker Report
2/24/2026
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, February 24, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
End of April (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 391 9740
Address
3160 Porter Drive
Palo Alto, CA 94304
Palo Alto, CA 94304
Country
Year Founded
Business Description
Sector
BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases. The company offers Attruby, a next-generation oral small...
more